MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1α expression

被引:150
|
作者
Lou, C. [1 ]
Xiao, M. [1 ]
Cheng, S. [1 ]
Lu, X. [1 ]
Jia, S. [1 ]
Ren, Y. [1 ]
Li, Z. [1 ]
机构
[1] Harbin Med Univ, Affiliated Tumor Hosp, Dept Breast Surg, 150 Haping Rd, Harbin 150081, Heilongjiang Pr, Peoples R China
来源
CELL DEATH & DISEASE | 2016年 / 7卷
关键词
PROLIFERATION; BIOGENESIS; MIGRATION; MICRORNAS;
D O I
10.1038/cddis.2016.27
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Breast cancer is the worldwide leading cause of cancer mortality in women. The majority of deaths from breast cancer arise from metastasis of local tumors. Cancer cells support their rapid proliferation by diverting metabolites into anabolic pathways, but during cancer metastasis, the proliferative program of invasive cancer cells is suspended for a migratory phenotype. In this study, we demonstrated that both mature forms of miRNA-485, miR-485-3p and miR-485-5p were involved in regulating mitochondrial respiration, cell migration and cell invasion in breast cancer cells by directly targeting and inhibiting the expression of PGC-1 alpha. Specifically, the expression levels of both miR-485-3p and miR-485-5p were decreased in breast cancer tissues. Overexpression of miR-485-3p and miR-485-5p suppressed mitochondrial respiration and potential for cell migration and invasion in vitro, and also inhibited spontaneous metastasis of breast cancer cells in vivo. The suppression of mitochondrial respiration and cell invasion could be partially relieved by restoration of PGC-1 alpha expression.
引用
收藏
页码:e2159 / e2159
页数:9
相关论文
共 50 条
  • [31] Fludarabine treatment favors the retention of miR-485-3p by prostate cancer cells: implications for survival
    Serena Lucotti
    Giuseppe Rainaldi
    Monica Evangelista
    Milena Rizzo
    Molecular Cancer, 12
  • [32] MicroRNA In Situ Hybridization Analysis of MiR-485-3p and MiR-122 Expression in Human Liver Development and Disease
    Sangokoya, Carolyn
    Mattis, Aras
    Ramachandran, Raga
    Baron, Jody
    MODERN PATHOLOGY, 2015, 28 : 423A - 423A
  • [33] Circ_0020460 drives tumorigenesis in cervical cancer through miR-485-3p sponging
    Kun Yan
    Chunyan Hu
    Yali Cheng
    Lingzhi Zheng
    Baojin Zeng
    Sujun Zhao
    Chen Liu
    Discover Oncology, 15
  • [34] Fludarabine treatment favors the retention of miR-485-3p by prostate cancer cells: implications for survival
    Lucotti, Serena
    Rainaldi, Giuseppe
    Evangelista, Monica
    Rizzo, Milena
    MOLECULAR CANCER, 2013, 12
  • [35] miR-485-5p alleviates Alzheimer's disease progression by targeting PACS1
    He, Chuan
    Su, Caixia
    Zhang, Wentong
    Wan, Qi
    TRANSLATIONAL NEUROSCIENCE, 2021, 12 (01) : 335 - 345
  • [36] miR-485-5p Binding Site SNP rs8752 in HPGD Gene Is Associated with Breast Cancer Risk
    He, Na
    Zheng, Hong
    Li, Pei
    Zhao, Yanrui
    Zhang, Wei
    Song, Fengju
    Chen, Kexin
    PLOS ONE, 2014, 9 (07):
  • [37] MiR-485-3p/MiR-543/MiR-337-3p is Required for the Oncogenic Potential of the Hsa_circ_0007385-MEMO1 Axis in Colorectal Cancer
    Ying, Junfeng
    Liu, Guanglan
    Zhu, Xinguo
    BIOCHEMICAL GENETICS, 2024, 62 (02) : 1182 - 1199
  • [38] Reduced Circulating Levels of miR-491-5p and miR-485-3p Are Associated with the Occurrence of Vertebral Fractures in Postmenopausal Women with Osteoporosis
    Xu, Jixi
    Li, Mingbo
    Pei, Wei
    Ding, Jinyong
    Pan, Yueran
    Peng, Huifeng
    Lin, Shiman
    Huang, Yanbo
    GENETICS RESEARCH, 2022, 2022
  • [39] MiR-485-3p modulates neural stem cell differentiation and proliferation via regulating TRIP6 expression
    Gu, Juxian
    Shao, Rusheng
    Li, Meng
    Yan, Qiuyue
    Hu, Hongwei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (01) : 398 - 404
  • [40] Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma
    Wang, Zhi-Qiang
    Zhang, Mei-Yin
    Deng, Mei-Ling
    Weng, Nuo-Qing
    Wang, Hui-Yun
    Wu, Shao-Xiong
    PLOS ONE, 2017, 12 (09):